Promoted inhibition of TLR4/miR-155/ NFkB p65 signaling by cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide

Citation:
Ali, A. M., O. S. El-Tawil, A. K. Al-Mokaddem, and S. A. S. El-Rahman, "Promoted inhibition of TLR4/miR-155/ NFkB p65 signaling by cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide", chemico-biological interaction, vol. 336, 2021.